Drug Patent Expirations for Dec 8, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

STRIVERDI RESPIMAT (olodaterol hydrochloride)
Boehringer Ingelheim
Patent number:6,453,795
Expiration Date:Dec 5, 2016

SPIRIVA RESPIMAT (tiotropium bromide)
Boehringer Ingelheim
Patent number:6,453,795
Expiration Date:Dec 5, 2016

COMBIVENT RESPIMAT (albuterol sulfate; ipratropium bromide)
Boehringer Ingelheim
Patent number:6,453,795
Expiration Date:Dec 5, 2016

STIOLTO RESPIMAT (olodaterol hydrochloride; tiotropium bromide)
Boehringer Ingelheim
Patent number:6,453,795
Expiration Date:Dec 5, 2016

AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER (moxifloxacin hydrochloride)
Bayer Hlthcare
Patent number:5,849,752
Expiration Date:Dec 5, 2016

AVELOX (moxifloxacin hydrochloride)
Bayer Hlthcare
Patent number:5,849,752
Expiration Date:Dec 5, 2016

SUMAVEL DOSEPRO (sumatriptan succinate)
Endo Ventures Ltd
Patent number:6,251,091
Expiration Date:Dec 9, 2016

PLENAXIS (abarelix)
Speciality European
Patent number:6,180,608
Expiration Date:Dec 11, 2016

PLENAXIS (abarelix)
Speciality European
Patent number:5,968,895
Expiration Date:Dec 11, 2016

PLENAXIS (abarelix)
Speciality European
Patent number:6,699,833
Expiration Date:Dec 11, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: